ArticleInternal medicine (Tokyo, Japan)2026

Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.

Shota Kaburaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.